Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

Nature Medicine
Victor AppaySarah L Rowland-Jones

Abstract

The viruses HIV-1, Epstein-Barr virus (EBV), cytomegalovirus (CMV) and hepatitis C virus (HCV) are characterized by the establishment of lifelong infection in the human host, where their replication is thought to be tightly controlled by virus-specific CD8+ T cells. Here we present detailed studies of the differentiation phenotype of these cells, which can be separated into three distinct subsets based on expression of the costimulatory receptors CD28 and CD27. Whereas CD8+ T cells specific for HIV, EBV and HCV exhibit similar characteristics during primary infection, there are significant enrichments at different stages of cellular differentiation in the chronic phase of persistent infection according to the viral specificity, which suggests that distinct memory T-cell populations are established in different virus infections. These findings challenge the current definitions of memory and effector subsets in humans, and suggest that ascribing effector and memory functions to subsets with different differentiation phenotypes is no longer appropriate.

References

Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·Q G MedleyP Anderson
Aug 1, 1996·Nature Medicine·M F CallanA J McMichael
Jan 1, 1996·Annual Review of Immunology·D J LenschowJ A Bluestone
Oct 4, 1996·Science·J D AltmanM M Davis
Nov 14, 1997·The Journal of Experimental Medicine·D HamannR A van Lier
Dec 22, 1998·The Journal of Experimental Medicine·S A Kalams, B D Walker
May 26, 1999·The Journal of Infection·P J Easterbrook
Feb 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·J M GraysonR Ahmed
May 3, 2000·The Journal of Experimental Medicine·F LechnerB D Walker
Jun 3, 2000·Annual Review of Immunology·P C Doherty, J P Christensen
Jul 6, 2000·The Journal of Experimental Medicine·V AppayS L Rowland-Jones
Aug 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·P A BaarsR A van Lier
Aug 31, 2000·Annual Review of Biochemistry·A StrasserV M Dixit
Nov 9, 2000·Immunology Today·A Globerson, R B Effros
Nov 22, 2000·The Journal of Clinical Investigation·M F CallanA J McMichael
Mar 10, 2001·Nature·P ChampagneG Pantaleo
Apr 27, 2001·Nature Immunology·M J Bevan, P J Fink
Aug 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A D HislopA B Rickinson
Jan 5, 2002·Immunity·Y M MuellerP D Katsikis

❮ Previous
Next ❯

Citations

Dec 15, 2004·European Journal of Immunology·Tania CroughRajiv Khanna
Aug 23, 2012·Archivum Immunologiae Et Therapiae Experimentalis·Erwin Daniel Brenndörfer, Matti Sällberg
Feb 10, 2006·Cancer Immunology, Immunotherapy : CII·Helena HarlinThomas F Gajewski
May 13, 2005·Cancer Immunology, Immunotherapy : CII·Javier G CasadoRaquel Tarazona
May 25, 2007·Cancer Immunology, Immunotherapy : CII·Lisa H ButterfieldJames S Economou
Jan 25, 2005·Springer Seminars in Immunopathology·Ena WangFrancesco M Marincola
Sep 13, 2006·Springer Seminars in Immunopathology·Rabih HalwaniRafick-Pierre Sékaly
Feb 28, 2008·Medical Microbiology and Immunology·Edward C P WallerMark R Wills
Oct 17, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M SantinF Gudiol
Dec 5, 2008·Journal of Clinical Immunology·Jens WrammertRafi Ahmed
Jan 19, 2011·Journal of Clinical Immunology·Christoph R ArnoldBeatrix Grubeck-Loebenstein
Sep 20, 2012·Journal of Clinical Immunology·Hossein Keshavarz ValianAli Khamesipour
May 30, 2009·Age·Sian M Henson, Arne N Akbar
Aug 11, 2005·Current HIV/AIDS Reports·Stephen A MiguelesMark Connors
Jan 20, 2009·Current HIV/AIDS Reports·Andrea LiscoLeonid Margolis
Dec 18, 2012·Current HIV/AIDS Reports·Marta MassanellaJulià Blanco
Sep 14, 2002·Current Infectious Disease Reports·Stephen A. Migueles, Mark Connors
Aug 5, 2004·Current Oncology Reports·Monica C PanelliFrancesco M Marincola
Dec 13, 2005·Cellular Immunology·Maria H NikolovaArmand Bensussan
Jun 14, 2005·Current Opinion in Immunology·Maria A SuniHolden T Maecker
Mar 31, 2004·Experimental Gerontology·Sudhir GuptaSastry Gollapudi
Apr 23, 2004·Trends in Molecular Medicine·Abbe N VallejoJörg J Goronzy
Mar 6, 2004·Seminars in Cancer Biology·Carmen ScheibenbogenUlrich Keilholz
Mar 6, 2004·Seminars in Cancer Biology·Vladia MonsurròFrancesco M Marincola
Mar 24, 2004·Trends in Microbiology·Jean-Michel Pawlotsky
Jun 12, 2003·Journal of Immunological Methods·Nadja AnikeevaYuri Sykulev
Apr 18, 2003·Journal of Theoretical Biology·Becca Asquith, Charles R M Bangham
Mar 20, 2004·Lancet·Andrea Kovacs, Mark Connors
Oct 12, 2001·Immunology Letters·S A Migueles, M Connors
Jan 1, 2003·Human Immunology·Adriana I ColovaiNicole Suciu-Foca
Oct 15, 2003·Blood Reviews·Maher K GandhiAndrew J Carmichael
Jun 29, 2002·Current Opinion in Immunology·Judy LiebermanPremlata Shankar
Aug 6, 2003·Current Opinion in Immunology·Natalya Serbina, Eric G Pamer
Aug 6, 2002·Current Opinion in Microbiology·Paul KlenermanRodney Phillips

❮ Previous
Next ❯

Related Concepts

Related Feeds

CZI Human Cell Atlas Seed Network

The aim of the Human Cell Atlas (HCA) is to build reference maps of all human cells in order to enhance our understanding of health and disease. The Seed Networks for the HCA project aims to bring together collaborators with different areas of expertise in order to facilitate the development of the HCA. Find the latest research from members of the HCA Seed Networks here.